about
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivityThe clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review.Evidence based application of BNP/NT-proBNP testing in heart failure.Laboratory challenges in primary aldosteronism screening and diagnosis.Evaluation of natriuretic peptide recommendations in heart failure clinical practice guidelines.Rates of inappropriate laboratory test utilization in Ontario.Clinical implications of estrone sulfate measurement in laboratory medicine.Health in Africa: international experience may provoke animosity towards those returning homeHigh-efficiency Semliki Forest virus-mediated transduction in bovine adrenal chromaffin cells.Exocytosis studies in a chromaffin cell-free system: imaging of single-vesicle exocytosis in a chromaffin cell-free system using total internal reflection fluorescence microscopy.Cortisol responses to the insulin hypoglycaemia test in children.Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight.Assessment of the Measurement Error in Cyclosporine Levels Drawn Between Peripheral and Central Sources.Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?Familial partial lipodystrophy presenting as metabolic syndrome.Reporting of post-polyethylene glycol prolactin: precipitation by polyethylene glycol 6000 or polyethylene glycol 8000 will change reference intervals for monomeric prolactin.Frameshift mutation in the APOA5 gene causing hypertriglyceridemia in a Pakistani family: Management and considerations for cardiovascular risk.Successful reintroduction of statin therapy after statin-associated rhabdomyolysis.Commutable samples with assigned target concentrations may help us harmonise general chemistry results.Requesting and interpreting urine albumin measurements in the primary health care settingMissed follow-up opportunities using a two-step screening approach for gestational diabetesReview of the prevalence of macroprolactinaemia in a South African hospitalApplicability of the AGREE II instrument in evaluating the development process and quality of current National Academy of Clinical Biochemistry guidelinesError detection in routine clinical chemistry laboratory test resultsDual reporting of hemoglobin A1C in the Canadian Journal of DiabetesEvaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS/MSLot change for reagents and calibrators
P50
Q34406791-2CCD0909-57F6-46BE-8A71-0555256410F4Q37869357-3DE1706A-9824-4A9B-BD82-7FF45950DC0BQ37871614-DA1DE804-43F9-4B99-BA05-45984E4E3B3DQ38275271-782362B8-756B-4CC4-A85B-291CA2696085Q38331798-96BC711C-7608-4184-8647-7FC22ABFE559Q38576463-DBB1BFFD-1B76-44E8-8DC2-50562DAB6B10Q38797326-5691D2DE-52AC-4632-B516-4C9C86C01B4CQ39037694-3209C18A-3992-401B-AB6D-748981121879Q42681137-3D7A7D85-EBB6-4CF9-8516-50E30DB272C9Q42994482-F0FDE90F-9436-42C4-954D-A262CB1DA6AFQ44220617-702C7F66-4058-43F7-944A-AA1CB9FD852DQ44674785-0AD9D586-0991-4374-9A52-011B1ED260C5Q47347763-0203D32E-BC07-4B07-9EE4-DD2EB840A917Q49612934-8AEB903D-A2EA-4565-A782-B6125D364772Q49711932-6214C102-9D4F-48FA-AE66-FEB469B2846DQ51284717-6CC41C71-6BA7-4257-8168-C31CC2FD066BQ51338067-F2626E01-148E-444C-BD5B-C5D280B18D84Q51454428-8397081E-CAA6-4B83-A8C8-D77F2AA65FF2Q53400031-C596511E-0D1A-4022-B80D-3736F9D743FAQ53934830-E677D3DA-7F78-46B6-8153-74CD7D871BFEQ82113489-5E2C7F5C-3075-4C57-8D8A-7C622B3FBB2DQ83474085-1D86BADF-A1E0-41B1-B912-F53203A254C9Q84165599-467B1B8D-1A16-4045-BE70-A8BC4A900528Q84765452-8509EEBB-4127-40E8-B45A-A86FCA24A4CAQ87128628-6DBBFFF2-12F3-4B27-A786-260F8BC3D5C2Q88038864-AE0A9362-D06B-4043-A398-133142C0EC66Q89024301-3D9F3A17-8E1D-4014-B161-F716C346C39FQ89400588-D8B65077-CAB2-4043-A1E8-CAFF83267CD8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrew C Don-Wauchope
@ast
Andrew C Don-Wauchope
@en
Andrew C Don-Wauchope
@es
Andrew C Don-Wauchope
@nl
type
label
Andrew C Don-Wauchope
@ast
Andrew C Don-Wauchope
@en
Andrew C Don-Wauchope
@es
Andrew C Don-Wauchope
@nl
prefLabel
Andrew C Don-Wauchope
@ast
Andrew C Don-Wauchope
@en
Andrew C Don-Wauchope
@es
Andrew C Don-Wauchope
@nl
P106
P21
P31
P496
0000-0003-2116-2423